DK1326963T3 - Mikroorganismer, som er gjort ikke-patogene - Google Patents
Mikroorganismer, som er gjort ikke-patogeneInfo
- Publication number
- DK1326963T3 DK1326963T3 DK01979874T DK01979874T DK1326963T3 DK 1326963 T3 DK1326963 T3 DK 1326963T3 DK 01979874 T DK01979874 T DK 01979874T DK 01979874 T DK01979874 T DK 01979874T DK 1326963 T3 DK1326963 T3 DK 1326963T3
- Authority
- DK
- Denmark
- Prior art keywords
- pathogenic
- control material
- made non
- microorganisms
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10161—Methods of inactivation or attenuation
- C12N2730/10163—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16061—Methods of inactivation or attenuation
- C12N2740/16063—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24363—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24103800P | 2000-10-17 | 2000-10-17 | |
PCT/US2001/032429 WO2002033129A2 (en) | 2000-10-17 | 2001-10-17 | Nucleic acid amplification controls |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1326963T3 true DK1326963T3 (da) | 2008-08-25 |
Family
ID=22908986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01979874T DK1326963T3 (da) | 2000-10-17 | 2001-10-17 | Mikroorganismer, som er gjort ikke-patogene |
Country Status (11)
Country | Link |
---|---|
US (5) | US20020076773A1 (es) |
EP (1) | EP1326963B1 (es) |
JP (2) | JP2004511251A (es) |
AT (1) | ATE396255T1 (es) |
AU (2) | AU2002211795C1 (es) |
CA (1) | CA2426172C (es) |
DE (1) | DE60134163D1 (es) |
DK (1) | DK1326963T3 (es) |
ES (1) | ES2306731T3 (es) |
PT (1) | PT1326963E (es) |
WO (1) | WO2002033129A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2784011T3 (es) | 2002-10-16 | 2020-09-21 | Streck Inc | Procedimiento y dispositivo para recoger y preservar las células para su análisis |
WO2004113872A2 (en) * | 2003-06-24 | 2004-12-29 | The Trustees Of Columbia University In The City Of New York | Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces |
WO2005040354A2 (en) * | 2003-10-24 | 2005-05-06 | Chiron Corporation | Sensitive monitor of anti-viral therapy |
US20090197275A1 (en) * | 2008-02-06 | 2009-08-06 | Acrometrix Corporation | Controls For Detecting Methicillin Resistant Staphylococcus Aureus (MRSA) |
GB0821834D0 (en) * | 2008-11-28 | 2009-01-07 | Iti Scotland Ltd | Calibration and control method |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
EP3290530B1 (en) | 2009-02-18 | 2020-09-02 | Streck Inc. | Preservation of cell-free nucleic acids |
DE102009025542A1 (de) * | 2009-06-19 | 2011-01-05 | Philipp Bauer | Neue Methode zur Isolation von Trichinella oder anderen Parasiten aus organischem Gewebe |
CA2765893C (en) | 2009-06-19 | 2017-08-01 | Philipp Bauer | New method for isolating trichinella or other parasites from organic tissue |
ES2938048T3 (es) | 2013-07-24 | 2023-04-04 | Streck Llc | Composiciones y procedimientos para estabilizar las células tumorales circulantes |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
EP3085774A1 (en) * | 2015-04-20 | 2016-10-26 | QIAGEN GmbH | Method for concentrating, purifying and/or isolating virus particles |
CN107636164B (zh) | 2015-05-29 | 2022-02-18 | 豪夫迈·罗氏有限公司 | 用柠康酸酐灭活微生物的方法 |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
AU2017239666B2 (en) * | 2016-03-31 | 2021-07-29 | Berkeley Lights, Inc. | Nucleic acid stabilization reagent, kits, and methods of use thereof |
WO2018022991A1 (en) | 2016-07-29 | 2018-02-01 | Streck, Inc. | Suspension composition for hematology analysis control |
WO2018031903A1 (en) | 2016-08-12 | 2018-02-15 | Streck, Inc. | Molecular reference controls |
BR112020023227A2 (pt) * | 2018-05-18 | 2021-02-23 | Microbix Biosystems Inc. | composições de controle de qualidade e materiais de controle de organismo inteiro para uso em teste de ácido nucleico |
IT201900008781A1 (it) | 2019-06-12 | 2020-12-12 | AB Analitica S R L | Metodo di amplificazione di acidi nucleici |
WO2024076805A2 (en) * | 2022-10-07 | 2024-04-11 | Zeptometrix Llc | Control for protein-based assay |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5135864A (en) | 1983-09-15 | 1992-08-04 | Institut Pasteur | Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor |
US4613501A (en) * | 1984-12-21 | 1986-09-23 | New York Blood Center, Inc. | Inactivation of viruses in labile blood derivatives |
US5777095A (en) | 1988-10-24 | 1998-07-07 | Symbicom Aktiebolag | Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 |
FR2691162B1 (fr) * | 1992-05-12 | 1994-07-08 | Aremas | Moyen pour le dosage quantitatif de retrovirus, procede pour sa preparation et kit de diagnostic comportant ledit moyen. |
DE69327891T2 (de) | 1992-07-06 | 2000-07-20 | Terumo Corp | Material zur Entfernung von pathogener Substanz und mit diesem Material hergestellter Blutfilter |
US5691132A (en) | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
JP3950500B2 (ja) | 1995-09-23 | 2007-08-01 | 独立行政法人水産総合研究センター | 魚類用のイリドウイルス感染症ワクチンと診断剤並びにこれ等の製法 |
US6072086A (en) * | 1996-04-12 | 2000-06-06 | Intergen Company | Method and composition for controlling formaldehyde fixation by delayed quenching |
AT405939B (de) | 1997-02-24 | 1999-12-27 | Immuno Ag | Verfahren zur inaktivierung von lipidumhüllten viren |
US6074825A (en) | 1997-07-31 | 2000-06-13 | Maine Medical Center | Stable encapsulated reference nucleic acid and method of making |
US5994078A (en) | 1997-07-31 | 1999-11-30 | Maine Medical Center | Stable encapsulated reference nucleic acid and method of making |
JP3159165B2 (ja) * | 1998-03-31 | 2001-04-23 | 日本電気株式会社 | 故障診断における推定論理状態管理方法及びその装置並びにプログラムを記録した機械読み取り可能な記録媒体 |
ES2252918T3 (es) | 1998-08-24 | 2006-05-16 | Pfizer Products Inc. | Cepa fiv-141 del virus de la inmunodeficiencia felina y sus usos. |
-
2001
- 2001-10-17 JP JP2002536097A patent/JP2004511251A/ja active Pending
- 2001-10-17 CA CA2426172A patent/CA2426172C/en not_active Expired - Lifetime
- 2001-10-17 DE DE60134163T patent/DE60134163D1/de not_active Expired - Lifetime
- 2001-10-17 AU AU2002211795A patent/AU2002211795C1/en not_active Expired
- 2001-10-17 DK DK01979874T patent/DK1326963T3/da active
- 2001-10-17 EP EP01979874A patent/EP1326963B1/en not_active Expired - Lifetime
- 2001-10-17 AT AT01979874T patent/ATE396255T1/de active
- 2001-10-17 US US09/981,506 patent/US20020076773A1/en not_active Abandoned
- 2001-10-17 ES ES01979874T patent/ES2306731T3/es not_active Expired - Lifetime
- 2001-10-17 AU AU1179502A patent/AU1179502A/xx active Pending
- 2001-10-17 PT PT01979874T patent/PT1326963E/pt unknown
- 2001-10-17 WO PCT/US2001/032429 patent/WO2002033129A2/en active Application Filing
-
2007
- 2007-04-18 JP JP2007109925A patent/JP4226046B2/ja not_active Expired - Lifetime
- 2007-10-30 US US11/929,089 patent/US9120849B2/en not_active Expired - Lifetime
- 2007-10-30 US US11/929,123 patent/US9127048B2/en not_active Expired - Lifetime
-
2015
- 2015-08-31 US US14/841,053 patent/US20150368727A1/en not_active Abandoned
-
2016
- 2016-12-29 US US15/394,085 patent/US20170107585A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60134163D1 (de) | 2008-07-03 |
US20080102445A1 (en) | 2008-05-01 |
CA2426172A1 (en) | 2002-04-25 |
JP2007185200A (ja) | 2007-07-26 |
ES2306731T3 (es) | 2008-11-16 |
WO2002033129A3 (en) | 2002-07-18 |
EP1326963B1 (en) | 2008-05-21 |
AU2002211795B2 (en) | 2007-10-11 |
WO2002033129A2 (en) | 2002-04-25 |
US20170107585A1 (en) | 2017-04-20 |
US9120849B2 (en) | 2015-09-01 |
ATE396255T1 (de) | 2008-06-15 |
EP1326963A2 (en) | 2003-07-16 |
US20020076773A1 (en) | 2002-06-20 |
AU2002211795C1 (en) | 2008-04-17 |
JP2004511251A (ja) | 2004-04-15 |
AU1179502A (en) | 2002-04-29 |
US9127048B2 (en) | 2015-09-08 |
PT1326963E (pt) | 2008-08-29 |
US20150368727A1 (en) | 2015-12-24 |
CA2426172C (en) | 2013-03-19 |
JP4226046B2 (ja) | 2009-02-18 |
US20080102446A1 (en) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1326963T3 (da) | Mikroorganismer, som er gjort ikke-patogene | |
DE3280150D1 (de) | Mikroorganismen fuer den mikrobiellen abbau von schaedlichen organischen abfallstoffen in unschaedliche materialien. | |
DE59908447D1 (de) | Verfahren zur Herstellung von hantelförmigen DNA-Molekülen als Expressionskonstrukte | |
NO20015400D0 (no) | Clostridiumstammer som produserer etanol fra substratinneholdende gasser | |
BR9807362A (pt) | Produção fermentativa de compostos úteis em escala industrial usando meios quimicamente definidos | |
DE60238493D1 (de) | Is von seltenen zellen verwendete markierte zellen | |
PL348448A1 (en) | Method of obtaining substances using micro-organisms | |
DE60138029D1 (de) | Verfahren zur herstellung von biopterinen | |
PT870016E (pt) | Enzimas sua preparacao e utilizacao na producao de acrilato de amonio | |
DK1546366T3 (da) | Fremgangsmåde til detektion og tælling af mikroorganismer i en pröve | |
DE60304456D1 (de) | Membran-hybridbioreaktor zur behandlung von städtischem und industriellem abwasser | |
DE60220989D1 (de) | Detektion von mikroorganismen | |
DE60210485D1 (de) | Verfahren zur bestimmung des vorhandenseins von bakterien, die gegen zell-lysierende antibiotika resistent sind | |
DE69917061D1 (de) | Nitrocumarine für den nachweis aller mikroorganismen | |
HUP0301217A2 (hu) | Anyagok és módszerek kénsav biológiai úton történő előállítására | |
ATE344321T1 (de) | Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen | |
DE60228089D1 (de) | Nukleinsäureamplifikation mit duplexzwischenprodukten | |
PT1343729E (pt) | Composicao microbiologica | |
ATE286487T1 (de) | Verfahren zur reinigung von wasser, dafür geeignete bakterien und deren verwendung | |
AU4397101A (en) | Method and kit for the detection of schistosomiasis through the polymerase chainreaction | |
EP0919633A3 (en) | Detection of Neisseria Gonorrhoeae by amplification and detection of its nucleic acid | |
ATE225859T1 (de) | Nachweis von antibiotikumresistenzen in mikroorganismen | |
ATE274576T1 (de) | 2,5-diketo-d-gluconsäure-reduktasen und deren anwendungen | |
DE69728911D1 (de) | Verfahren zur bekämpfung von mikroorganismen | |
ATE424446T1 (de) | Zur oxidation von arsen verwendbare bakterien, verfahren zu ihrer selektion und ihre verwendung zur aufbereitung von arsenhaltigen medien |